U.S. markets open in 7 hours 23 minutes
  • S&P Futures

    3,602.75
    +26.75 (+0.75%)
     
  • Dow Futures

    29,797.00
    +251.00 (+0.85%)
     
  • Nasdaq Futures

    11,971.75
    +66.50 (+0.56%)
     
  • Russell 2000 Futures

    1,838.20
    +21.10 (+1.16%)
     
  • Crude Oil

    43.67
    +0.61 (+1.42%)
     
  • Gold

    1,825.50
    -12.30 (-0.67%)
     
  • Silver

    23.43
    -0.20 (-0.84%)
     
  • EUR/USD

    1.1855
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    0.8570
    0.0000 (0.00%)
     
  • Vix

    22.66
    -1.04 (-4.39%)
     
  • GBP/USD

    1.3342
    +0.0020 (+0.15%)
     
  • USD/JPY

    104.4440
    -0.0440 (-0.04%)
     
  • BTC-USD

    18,392.42
    +59.91 (+0.33%)
     
  • CMC Crypto 200

    368.51
    +7.08 (+1.96%)
     
  • FTSE 100

    6,333.84
    -17.61 (-0.28%)
     
  • Nikkei 225

    26,165.59
    +638.22 (+2.50%)
     

Rigel: 3Q Earnings Snapshot

·1 min read

SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Thursday reported a loss of $14.2 million in its third quarter.

The South San Francisco, California-based company said it had a loss of 8 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.

The drug developer posted revenue of $18.4 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $17.6 million.

In the final minutes of trading on Thursday, the company's shares hit $2.74. A year ago, they were trading at $2.17.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL